{"id":"https://openalex.org/W2240935355","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11504","title":"Health economic analysis of breast cancer index in patients with ER+, LN- breast cancer.","display_name":"Health economic analysis of breast cancer index in patients with ER+, LN- breast cancer.","publication_year":2013,"publication_date":"2013-05-20","ids":{"openalex":"https://openalex.org/W2240935355","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11504","mag":"2240935355"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.15_suppl.e11504","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047991970","display_name":"Gary George Gustavsen","orcid":"https://orcid.org/0000-0003-0382-6062","observed_orcids":["https://orcid.org/0000-0003-0382-6062"]},"institutions":[{"id":"https://openalex.org/I4210141923","display_name":"Health Advances (United States)","ror":"https://ror.org/03t8n7w93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Gustavsen","raw_affiliation_strings":["Health Advances, LLC, Weston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Advances, LLC, Weston, MA","institution_ids":["https://openalex.org/I4210141923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054148161","display_name":"Brock E. Schroeder","orcid":"https://orcid.org/0000-0002-0803-7209","observed_orcids":["https://orcid.org/0000-0002-0803-7209"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brock Schroeder","raw_affiliation_strings":["bioTheranostics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioTheranostics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Patrick Kennedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141923","display_name":"Health Advances (United States)","ror":"https://ror.org/03t8n7w93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Kennedy","raw_affiliation_strings":["Health Advances, LLC, Weston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Advances, LLC, Weston, MA","institution_ids":["https://openalex.org/I4210141923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087054566","display_name":"Kristin Ciriello Pothier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141923","display_name":"Health Advances (United States)","ror":"https://ror.org/03t8n7w93","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin Ciriello Pothier","raw_affiliation_strings":["Health Advances, LLC, Weston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Advances, LLC, Weston, MA","institution_ids":["https://openalex.org/I4210141923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002982469","display_name":"Catherine A. Schnabel","orcid":"https://orcid.org/0009-0006-5500-9290","observed_orcids":["https://orcid.org/0009-0006-5500-9290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine A. Schnabel","raw_affiliation_strings":["bioTheranostics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioTheranostics, Inc., San Diego, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003109423","display_name":"Mark G. Erlander","orcid":"https://orcid.org/0000-0002-4231-7095","observed_orcids":["https://orcid.org/0000-0002-4231-7095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark G. Erlander","raw_affiliation_strings":["bioTheranostics, Inc., San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"bioTheranostics, Inc., San Diego, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"15_suppl","first_page":"e11504","last_page":"e11504"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.10599999874830246,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer-index","display_name":"Breast Cancer Index","score":0.9909999966621399},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.765999972820282},{"id":"https://openalex.org/keywords/node-negative-breast-cancer","display_name":"node-negative breast cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cost-utility-analysis","display_name":"cost-utility analysis","score":0.5329999923706055},{"id":"https://openalex.org/keywords/extended-endocrine-therapy","display_name":"extended endocrine therapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/recurrence-risk-prediction","display_name":"recurrence risk prediction","score":0.550000011920929},{"id":"https://openalex.org/keywords/third-party-payer-perspective","display_name":"third-party payer perspective","score":0.7490000128746033},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.890300989151001},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.8245437145233154},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6151621341705322},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5552538633346558},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4724721610546112},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4679397940635681},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4110921621322632},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.15_suppl.e11504","doi":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11504","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.15_suppl.e11504","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2043697582","https://openalex.org/W2604270622","https://openalex.org/W2598583756","https://openalex.org/W2624161141","https://openalex.org/W4415942289","https://openalex.org/W2920314878","https://openalex.org/W2073979386","https://openalex.org/W7117544853","https://openalex.org/W3156155622","https://openalex.org/W2396385043"],"abstract_inverted_index":{"e11504":[0],"Background:":[1],"Numerous":[2],"studies":[3,314],"have":[4],"demonstrated":[5,242],"the":[6,73,94,120,174],"cost":[7,75,95,184,193,206,256,260,277],"utility":[8,76],"of":[9,13,26,49,56,77,98,104,125,178,195,216,257,261,265,315],"gene":[10,41],"expression-based":[11,42],"assessment":[12],"recurrence":[14,53,140,221,234],"risk":[15,48],"in":[16,29,63,100,186,222,235,251,279,310],"breast":[17,68,109,283],"cancer.":[18,69],"Cost":[19,287],"savings":[20,194,207,288],"rely":[21],"primarily":[22,150],"on":[23,123,151,173,229,294],"decreased":[24],"use":[25,215],"adjuvant":[27,133,217,258,295],"chemotherapy":[28,218,249,296],"patients":[30,64,105,223,238,266],"predicted":[31],"to":[32,112,170,182,210,248,275],"be":[33,183,211,276],"low-risk.":[34],"Breast":[35],"Cancer":[36],"Index":[37],"(BCI)":[38],"is":[39,180,273],"a":[40,80,101,191],"test":[43],"that":[44,243],"significantly":[45],"predicts":[46],"overall":[47],"recurrence,":[50,262],"late":[51],"(\u22655y)":[52,60],"and":[54,96,127,139,154,161,232,253,263,302],"likelihood":[55],"benefit":[57],"from":[58,79],"extended":[59,225,298],"endocrine":[61,137,226,299,303],"therapy":[62,227,300,304],"with":[65,106,132,158,190],"ER+,":[66,107,281],"LN-":[67,108],"This":[70],"study":[71],"evaluated":[72],"potential":[74],"BCI":[78,99,128,179,203,230,272],"US":[81],"third-party":[82],"payer":[83],"perspective.":[84],"Methods:":[85],"A":[86],"fact-based":[87],"economic":[88],"model":[89,121],"was":[90],"developed":[91],"which":[92],"projected":[93,181,209,274,292],"effectiveness":[97],"hypothetical":[102],"population":[103],"cancer":[110,284],"compared":[111],"standard":[113],"clinicopathologic":[114],"diagnostic":[115],"modalities.":[116],"Patients":[117],"flowed":[118],"through":[119,213,291],"based":[122,149,228],"patterns":[124],"care":[126],"data.":[129],"Costs":[130],"associated":[131],"chemotherapy,":[134,259],"toxicity,":[135],"follow-up,":[136],"therapy,":[138],"were":[141,148,165,208,245],"modeled":[142],"over":[143],"10":[144],"yrs.":[145],"Model":[146],"inputs":[147,169],"published":[152],"literature,":[153],"supplemented":[155],"by":[156],"interviews":[157],"disease":[159],"experts":[160],"payers.":[162],"Sensitivity":[163,240],"analyses":[164,241],"performed":[166],"around":[167],"key":[168],"estimate":[171],"effects":[172],"model.":[175],"Results:":[176],"Use":[177],"saving":[185,278],"this":[187],"patient":[188,198,285],"population,":[189],"net":[192],"$4,005":[196],"per":[197],"tested":[199],"after":[200],"accounting":[201],"for":[202],"cost.":[204],"Gross":[205],"achieved":[212,290],"targeted":[214],"($5,785),":[219],"reduced":[220,233],"receiving":[224],"($2,350),":[231],"previously":[236],"non-compliant":[237],"($370).":[239],"results":[244],"most":[246],"sensitive":[247],"utilization":[250],"low-":[252],"intermediate-risk":[254],"patients,":[255],"percentage":[264],"classified":[267],"as":[268],"low":[269],"risk.":[270],"Conclusions:":[271],"an":[280],"LN-,":[282],"population.":[286],"are":[289],"impact":[293],"use,":[297,301],"compliance.":[305],"These":[306],"findings":[307],"require":[308],"validation":[309],"additional":[311],"cohorts,":[312],"including":[313],"real-world":[316],"clinical":[317],"practice.":[318]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}